Free Trial

DiaSorin (DSRLF) News Today

DiaSorin logo
$107.68 0.00 (0.00%)
As of 07/15/2025

DSRLF Latest News

DiaSorin S.p.A. (0GZX) Receives a Hold from Barclays
DiaSorin S.p.A. (0GZX) Receives a Sell from Kepler Capital
DiaSorin stock rises despite mixed financial results
UBS Remains a Hold on DiaSorin S.p.A. (0GZX)
Kepler Capital Sticks to Its Sell Rating for DiaSorin S.p.A. (0GZX)
DiaSorin S.p.A. (0GZX) Receives a Hold from RBC Capital
Kepler Capital Reaffirms Their Sell Rating on DiaSorin S.p.A. (0GZX)
DSRLF DiaSorin S.p.A.
DiaSorin SpA ADR (DASOY)
Diasorin SpA DSRLF
Diasorin SpA DIA
DiaSorin S.p.A. reports 1H results
DiaSorin S.p.A.
DiaSorin: Overvalued Italian Healthcare Company
Get DiaSorin News Delivered to You Automatically

Sign up to receive the latest news and ratings for DSRLF and its competitors with MarketBeat's FREE daily newsletter.

DSRLF Media Mentions By Week

DSRLF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DSRLF
News Sentiment

0.00

0.95

Average
Medical
News Sentiment

DSRLF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DSRLF Articles
This Week

0

0

DSRLF Articles
Average Week

Get DiaSorin News Delivered to You Automatically

Sign up to receive the latest news and ratings for DSRLF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (OTCMKTS:DSRLF) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners